Glycemic impact of gabapentin and Nucleo C.M.P in metformin-controlled diabetic patients: A case report
This study examines the contraindications of gabapentin and Nucleo C.M.P Forte in metformin-controlled diabetic patients, focusing on their potential to induce hyperglycemia. A case report of a 65-year-old woman with type II diabetes is presented, demonstrating elevated blood glucose levels followin...
| Published in: | SAGE Open Medical Case Reports |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-07-01
|
| Online Access: | https://doi.org/10.1177/2050313X241265072 |